Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Publication

Article

April 20, 2007

CURE

Special Issue 2007
Volume6
Issue 3

Navigation As Support

Author(s):

Kathy LaTour

Some breast cancer patients are finding help with their diagnosis in patient navigators—a person who has been trained to serve as a personal guide through cancer.

For some women across the country, a breast cancer diagnosis brings with it a patient navigator, a former patient or hospital patient educator who has been trained to serve as a personal guide through the psychological, emotional and financial challenges of cancer.

Started in 1990 by Harold Freeman, MD, founder and medical director of Harlem’s Ralph Lauren Center for Cancer Care and Prevention, the patient navigator program has expanded to 60 sites across the country through the American Cancer Society, which launched a program in 2005 to specifically reach underserved populations. In early 2007, the drug company AstraZeneca donated $10 million to the ACS to add at least another 50 patient navigator sites over the next five years. In other settings, psychosocial support may be provided by an oncology social worker, oncology nurse, nurse practitioner or chaplain.

In Denver, Sandra Walters, RN, left her hospital position to open the Andre Center for Breast Cancer Education and Navigation, a community-based outreach program. Serving as an educator and care coordinator to help guide women through breast cancer, Walters sees her role as critical in providing women with an educated medical professional who is not providing treatment but has an in-depth understanding of breast cancer and treatment.

"The biggest hindrance to getting through a breast cancer diagnosis intact is anxiety and fear,” she says. “You address those issues by reaching out and saying, ‘I am going to help you understand and get through this."

The biggest hinderance to getting through a breast cancer diagnosis intact is anxiety and fear. You address those issues by reaching out and saying, ‘I am going to help you understand and get through this.'

In the eight years before beginning the Andre Center, Walters helped develop two hospital-based breast cancer programs, where she worked with hundreds of patients. “I know the value of timely, upfront education and the benefit it brings in decreasing anxiety through one-on-one education and compassion,” she says.

Walters also knows the challenges of creating and maintaining a patient navigator position in hospitals because of the pressures of managed care and time, but “if it’s done right, it will pay for itself through downstream revenue. It’s making the commitment to the process that has to happen.”

Articles in this issue

To Catch a Cancer
Screening for Recurrent Breast Cancer
A New Era
The Comforts of Help
Eluding Cancer
Navigation As Support
The Lifestyle Approach
The Law of Distraction
What Stage Is Your Breast Cancer?
Optimism for Inflammatory Breast Cancer
Message from the Editor

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Content
Advertisement
Image of hand.
June 10th 2025

Oncology Nurse Amanda Snyder Turns Personal Experience Into Advocacy

Jeanine Pronio
Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
June 7th 2025

Utilizing AI in Prostate Cancer Care and Management

Alex Biese
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine in advanced kidney cancer: © stock.adobe.com.
June 6th 2025

Personalized Vaccine Elicits Responses in Patients With Kidney Cancer

Alex Biese
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced kidney cancer.
New treatment combinations are transforming genitourinary cancer care: © stock.adobe.com.
May 30th 2025

Rapid Developments to Enhance Patient Experience in GU Cancer

Dr. John L. Gore
New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq: © stock.adobe.com
May 30th 2025

Additive Antihistamines May Improve Metastatic Bladder Cancer Outcomes

Alex Biese
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq.
A powerful new ally is emerging in cancer care: artificial intelligence: © stock.adobe.com.
May 27th 2025

The Dawn of AI in Prostate Cancer Care

Mike Hennessy Jr.
A powerful new ally is emerging in cancer care: artificial intelligence.
Related Content
Advertisement
Image of hand.
June 10th 2025

Oncology Nurse Amanda Snyder Turns Personal Experience Into Advocacy

Jeanine Pronio
Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
June 7th 2025

Utilizing AI in Prostate Cancer Care and Management

Alex Biese
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine in advanced kidney cancer: © stock.adobe.com.
June 6th 2025

Personalized Vaccine Elicits Responses in Patients With Kidney Cancer

Alex Biese
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced kidney cancer.
New treatment combinations are transforming genitourinary cancer care: © stock.adobe.com.
May 30th 2025

Rapid Developments to Enhance Patient Experience in GU Cancer

Dr. John L. Gore
New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq: © stock.adobe.com
May 30th 2025

Additive Antihistamines May Improve Metastatic Bladder Cancer Outcomes

Alex Biese
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq.
A powerful new ally is emerging in cancer care: artificial intelligence: © stock.adobe.com.
May 27th 2025

The Dawn of AI in Prostate Cancer Care

Mike Hennessy Jr.
A powerful new ally is emerging in cancer care: artificial intelligence.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.